NCT04674644 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Ahmed O, Faisal RA, Sharker T, Lee SA, Jobe MC
Adaptation of the Bangla Version of the COVID-19 Anxiety Scale. Int J Ment Health Addict. 2020 Jun 27:1-12. doi: 10.1007/s11469-020-00357-2. [Epub ahead of print]
Alyami M, Henning M, Krägeloh CU, Alyami H
Psychometric Evaluation of the Arabic Version of the Fear of COVID-19 Scale. Int J Ment Health Addict. 2020 May 16:1-14. doi: 10.1007/s11469-020-00316-x. [Epub ahead of print]
Andrade EF, Pereira LJ, Oliveira APL, Orlando DR, Alves DAG, Guilarducci JS, Castelo PM
Perceived fear of COVID-19 infection according to sex, age and occupational risk using the Brazilian version of the Fear of COVID-19 Scale. Death Stud. 2020 Aug 26:1-10. doi: 10.1080/07481187.2020.1809786. [Epub ahead of print]
Mahmood QK, Jafree SR, Qureshi WA
The Psychometric Validation of FCV19S in Urdu and Socio-Demographic Association with Fear in the People of the Khyber Pakhtunkhwa (KPK) Province in Pakistan. Int J Ment Health Addict. 2020 Jul 12:1-11. doi: 10.1007/s11469-020-00371-4. [Epub ahead of print]

Suleyman Demirel University Faculty of Dentistry Pediatric Dentistry Department

Clinical trial NCT04674644 - References